Trials / Completed
CompletedNCT01027208
A Rollover Study of Ixabepilone (BMS-247550) In Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline
A Rollover Study of Ixabepilone (BMS-247550) In Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline And Who Are Taxane Resistant Who Have Completed Study CA163107 And Who Are Benefiting From Continuation On Therapy With Ixabepilone
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- R-Pharm · Industry
- Sex
- Female
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
To provide extended access to Ixabepilone therapy to subjects with metastatic breast cancer who have completed the previous Phase II study (CA163-107)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ixabepilone | Lyophilized and solvent, IV, 10-50 mg/m² |
Timeline
- Start date
- 2006-12-01
- Primary completion
- 2007-01-01
- Completion
- 2007-01-01
- First posted
- 2009-12-07
- Last updated
- 2017-01-30
Locations
14 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01027208. Inclusion in this directory is not an endorsement.